Suppression of the IgE-dependent allergic response by benzimidazole analogs
US6271390A · kind A · utility
8Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 1999 |
| Grant date | Aug 7, 2001 |
| Priority date | — |
| Expiry date | May 21, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to small molecule inhibitors of the IgE response to allergens which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.